These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34266360)
21. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study. Fares AR; ElMeshad AN; Kassem MAA Drug Deliv; 2018 Nov; 25(1):132-142. PubMed ID: 29275642 [TBL] [Abstract][Full Text] [Related]
22. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies. Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921 [TBL] [Abstract][Full Text] [Related]
23. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route. Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709 [TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models. Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435 [TBL] [Abstract][Full Text] [Related]
25. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ". Shah B; Khunt D; Misra M; Padh H Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654 [TBL] [Abstract][Full Text] [Related]
26. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792 [TBL] [Abstract][Full Text] [Related]
27. Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies. Elsenosy FM; Abdelbary GA; Elshafeey AH; Elsayed I; Fares AR Int J Nanomedicine; 2020; 15():9517-9537. PubMed ID: 33324051 [TBL] [Abstract][Full Text] [Related]
28. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628 [TBL] [Abstract][Full Text] [Related]
29. Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation. Hosny KM Int J Nanomedicine; 2020; 15():5113-5129. PubMed ID: 32764940 [TBL] [Abstract][Full Text] [Related]
30. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. Abdelrahman FE; Elsayed I; Gad MK; Badr A; Mohamed MI Int J Pharm; 2015 Jul; 490(1-2):281-91. PubMed ID: 26026251 [TBL] [Abstract][Full Text] [Related]
31. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: Abd-Elhakeem E; El-Nabarawi M; Shamma R Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration. Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV Drug Deliv; 2016; 23(1):307-15. PubMed ID: 24845478 [TBL] [Abstract][Full Text] [Related]
33. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Sharma S; Lohan S; Murthy RS Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649 [TBL] [Abstract][Full Text] [Related]
34. Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation. Patel MR; Patel RB; Bhatt KK; Patel BG; Gaikwad RV Drug Deliv; 2016; 23(1):346-54. PubMed ID: 24865295 [TBL] [Abstract][Full Text] [Related]
35. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route. Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095 [TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting. Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580 [TBL] [Abstract][Full Text] [Related]
37. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies. Shelke S; Shahi S; Jalalpure S; Dhamecha D J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957 [TBL] [Abstract][Full Text] [Related]
39. Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies. Gadhave D; Khot S; Tupe S; Shinde M; Tagalpallewar A; Gorain B; Kokare C Int J Pharm; 2022 Dec; 629():122372. PubMed ID: 36351503 [TBL] [Abstract][Full Text] [Related]
40. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation. Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]